BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17721319)

  • 1. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of high-risk human papillomavirus detection in women aged > or = 50 years with atypical squamous cells of undetermined significance cytologic preparations.
    Rosario D; Zahn CM; Bush AC; Kendall BS
    Cancer; 2007 Dec; 111(6):487-90. PubMed ID: 17973252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
    Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
    Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
    Zhao C; Austin RM
    Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
    Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
    Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
    Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
    Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
    Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
    J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between hybrid capture II high-risk human papillomavirus DNA test chemiluminescence intensity from cervical samples with follow-up histologic results: a cytologic/histologic review of 367 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Cancer Cytopathol; 2010 Aug; 118(4):209-17. PubMed ID: 20578088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.
    Zuna RE; Moore W; Dunn ST
    Mod Pathol; 2001 Mar; 14(3):147-51. PubMed ID: 11266518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
    Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anal cytology: is there a role for reflex HPV DNA testing?
    Walts AE; Thomas P; Bose S
    Diagn Cytopathol; 2005 Sep; 33(3):152-6. PubMed ID: 16078257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing.
    Johnston EI; Logani S
    Cancer; 2007 Jun; 111(3):160-5. PubMed ID: 17506090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human papilloma virus DNA in cervical samples with cytological abnormalities and typing of the virus].
    Ergünay K; Misirlioğlu M; Pinar F; Tuncer ZS; Tuncer S; Ustaçelebi S
    Mikrobiyol Bul; 2007 Apr; 41(2):219-26. PubMed ID: 17682708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.
    de Cremoux P; Coste J; Sastre-Garau X; Thioux M; Bouillac C; Labbé S; Cartier I; Ziol M; Dosda A; Le Galès C; Molinié V; Vacher-Lavenu MC; Cochand-Priollet B; Vielh P; Magdelénat H;
    Am J Clin Pathol; 2003 Oct; 120(4):492-9. PubMed ID: 14560561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.